Philippines Moves to Ban Open-System Vape Cartridges and Uncertified E-Liquids, Removes Several Devices from Compliance List

Oct.21.2025
Philippines Moves to Ban Open-System Vape Cartridges and Uncertified E-Liquids, Removes Several Devices from Compliance List
DTI plans nationwide ban on open system pods and unlicensed e-liquids to ensure consumer safety and health.

Key points

 

  • The Department of Trade and Industry (DTI) in the Philippines is considering a nationwide ban on open pod systems and unregistered e-liquids, covering all aspects of production, importation, distribution, and retail. 
  • They have removed open pod systems from the list of permitted products to ensure that only compliant e-cigarette products enter the market and retail networks.
  •  This decision comes after the Philippine Drug Enforcement Agency (PDEA) reported the detection of synthetic cannabinoids, shifting regulatory focus towards ingredient risks and protection of youth through evidence-based enforcement. 
  • The DTI is planning to issue a regulatory ban in accordance with RA 11900, establishing a standardized list of permits and reporting channels.

 


 

 2Firsts,on October 20, 2025——According to an announcement on the official website of the Department of Trade and Industry (DTI) in the Philippines the DTI is intensifying efforts to regulate the production, importation, distribution, and sale of vape open pods and uncertified e-liquids. The goal of these measures is to reduce consumer safety and health risks.

 

The Department of Trade and Industry (DTI) has removed a specific model of open system pod from the scope of the Philippine Standard (PS) certification to ensure that only products that meet the specified standards can be sold to the public.

 

At the same time, e-cigarette company Phantom Vape Group, Inc. has voluntarily reduced the coverage of its PS Certificate No. Q-00002, excluding open-system models under the VAGEND brand such as the VPRIME Device, XLIM PRO 2 Device, NEXLIM Device, XLIM GO Device, and XLIM SQ PRO 2 Device. This means that the mentioned products are no longer authorized for production, import, distribution, or retail within the Philippines.

 

According to reports, DTI's move also responds to concerns in society about e-cigarette products suspected of containing synthetic cannabinoids. The Philippine Drug Enforcement Agency (PDEA) recently detected synthetic chemical substances in "Tuklaw" tobacco that can mimic the effects of marijuana, prompting regulatory alerts.

 

The Office for the Special Mandate on Vaporized Nicotine and Non-Nicotine Products, their Devices, and Novel Tobacco Products, a subordinate agency of the Department of Trade and Industry (DTI), is finalizing regulatory documents to institutionalize the nationwide ban on open-pod systems and uncertified e-liquids.

 

The Department of Trade and Industry (DTI) emphasizes that it will continue to fulfill its consumer protection responsibilities in accordance with the Vaporized Nicotine and Non-Nicotine Products Regulation Act (RA 11900), on the regulation of nicotine and non-nicotine products. The DTI will also regularly update the list of permit holders for public safety, which will benefit both industry stakeholders and the general public in accessing information.

 

After 2Firrsts conducting research, it was found that the recently popular "Tuklaw" tobacco in the Philippines originates from the mountainous regions of Vietnam, with extremely high nicotine content and often containing synthetic cannabinoids. As a result, Philippine regulatory authorities have issued a warning that this product may lead to serious health risks such as epileptic seizures and hallucinations.

 

Image source: Department of Trade and Industry (DTI) of the Philippines.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMI CEO Attends Opening of IQOS Global Flagship in Tokyo’s Ginza as 1,814 Limited ILUMA i PRIME Sets Launch
PMI CEO Attends Opening of IQOS Global Flagship in Tokyo’s Ginza as 1,814 Limited ILUMA i PRIME Sets Launch
IQOS opened its first global flagship, IQOS Flagship Ginza, in Tokyo on September 4, 2026, replacing the former IQOS Store Ginza after nearly a decade of operation. The new location expands conventional product retail into member lounges, digital experiences, art installations and brand programming. IQOS also launched a Ginza-exclusive IQOS ILUMA i PRIME set limited to 1,814 individually numbered units, priced at JPY11,980, or about US$77. PMI Sales Strategy Consultant Yuji M. later said on LinkedIn that more than 500 people had lined up from the night before the opening.
Sep.07
UK Directors Banned After 352,688 Vapes Imported From China Were Misdeclared as Medical Nebulizers in £15 Million Tax Case
UK Directors Banned After 352,688 Vapes Imported From China Were Misdeclared as Medical Nebulizers in £15 Million Tax Case
The UK Insolvency Service said YSK Enterprises imported large quantities of vapes from China in 2023, with a shipment addressed to the company declared as medical nebulizers before Border Force found 352,688 vaping products. HMRC calculated nearly £15 million ($20.3 million) in unpaid VAT and customs duty, alongside about £437,000 in corporation tax. Two directors were disqualified for nine years. The case predates the UK's Vaping Products Duty, which will introduce vape-specific excise and duty-stamp requirements from October 2026.
Regulations
Sep.11
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
The Trump administration is preparing changes intended to accelerate FDA market authorization reviews for e-cigarettes and nicotine pouches, according to The Wall Street Journal. The FDA is expected to revisit its 2021 PMTA rule and may simplify some scientific study requirements and shorten review times. The agency has not formally announced the changes. Over the past year, the FDA has already accelerated nicotine-pouch reviews, expanded ENDS authorizations and upgraded its CTP Portal NextGen application system. As of August 2026, 43 nicotine pouch products and 48 e-cigarette products had received FDA marketing authorization.
Sep.24
Gallup Tracks Nicotine Pouch Use for the First Time: 11% of U.S. Adults Smoke, 9% Vape and 4% Use Nicotine Pouches
Gallup Tracks Nicotine Pouch Use for the First Time: 11% of U.S. Adults Smoke, 9% Vape and 4% Use Nicotine Pouches
Gallup’s 2026 Consumption Habits survey tracked nicotine pouch use for the first time. The survey found that 11% of U.S. adults reported smoking cigarettes in the past week, 9% reported vaping, and 4% reported using nicotine pouches. Cigarette smoking remained near Gallup’s long-term low, while adult vaping rates stayed relatively stable in recent years.
Market
Aug.25 by 2Firsts Perspectives
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
UK Sets Oct. 29 Start for New Vape Retail Rules Covering Age Checks, Giveaways and Discounts
UK Sets Oct. 29 Start for New Vape Retail Rules Covering Age Checks, Giveaways and Discounts
The UK Department of Health and Social Care published new guidance on Aug. 11 outlining the next phase of retail rules under the Tobacco and Vapes Act 2026, which will take effect on Oct. 29, 2026. The measures extend the minimum age of sale of 18 to all vaping and consumer nicotine products and restrict proxy purchasing, promotional giveaways and substantial discounts. Relevant offences in England, Wales and Scotland may carry a £200 fixed penalty notice, while persistent offenders can face temporary sales bans.
Aug.12